SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1MEF - Registration statement to add securities to prior Form F-1 registration [Rule 462(b)]:
SEC Accession No. 0001213900-19-008325
Filing Date
2019-05-13
Accepted
2019-05-13 06:20:57
Documents
5
Effectiveness Date
2019-05-13

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ff1mef2019_aurismedical.htm F-1MEF 60809
2 OPINION OF CONYERS DILL & PEARMAN LIMITED, BERMUDA COUNSEL TO THE COMPANY, AS TO ff1mef2019ex5-1_auris.htm EX-5.1 20057
3 OPINION OF LOWENSTEIN SANDLER LLP, U.S. COUNSEL TO THE COMPANY, AS TO THE VALIDI ff1mef2019ex5-2_auris.htm EX-5.2 11650
4 CONSENT OF DELOITTE AG ff1mef2019ex23-1_auris.htm EX-23.1 5165
5 GRAPHIC ex23_001.jpg GRAPHIC 7656
  Complete submission text file 0001213900-19-008325.txt   109671
Mailing Address BAHNHOFSTRASSE 21 6300 ZUG V8 00000
Business Address BAHNHOFSTRASSE 21 6300 ZUG V8 00000 41 (0)61 201 13 50
Auris Medical Holding Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: F-1MEF | Act: 33 | File No.: 333-231403 | Film No.: 19816848
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1